These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
481 related items for PubMed ID: 22093185
1. Autism-like behaviours with transient histone hyperacetylation in mice treated prenatally with valproic acid. Kataoka S, Takuma K, Hara Y, Maeda Y, Ago Y, Matsuda T. Int J Neuropsychopharmacol; 2013 Feb; 16(1):91-103. PubMed ID: 22093185 [Abstract] [Full Text] [Related]
3. Oxytocin attenuates deficits in social interaction but not recognition memory in a prenatal valproic acid-induced mouse model of autism. Hara Y, Ago Y, Higuchi M, Hasebe S, Nakazawa T, Hashimoto H, Matsuda T, Takuma K. Horm Behav; 2017 Nov; 96():130-136. PubMed ID: 28942000 [Abstract] [Full Text] [Related]
5. Reduced prefrontal dopaminergic activity in valproic acid-treated mouse autism model. Hara Y, Takuma K, Takano E, Katashiba K, Taruta A, Higashino K, Hashimoto H, Ago Y, Matsuda T. Behav Brain Res; 2015 Aug 01; 289():39-47. PubMed ID: 25907743 [Abstract] [Full Text] [Related]
6. Impaired repair of DNA damage is associated with autistic-like traits in rats prenatally exposed to valproic acid. Servadio M, Manduca A, Melancia F, Leboffe L, Schiavi S, Campolongo P, Palmery M, Ascenzi P, di Masi A, Trezza V. Eur Neuropsychopharmacol; 2018 Jan 01; 28(1):85-96. PubMed ID: 29174949 [Abstract] [Full Text] [Related]
7. Male-specific alteration in excitatory post-synaptic development and social interaction in pre-natal valproic acid exposure model of autism spectrum disorder. Kim KC, Kim P, Go HS, Choi CS, Park JH, Kim HJ, Jeon SJ, Dela Pena IC, Han SH, Cheong JH, Ryu JH, Shin CY. J Neurochem; 2013 Mar 01; 124(6):832-43. PubMed ID: 23311691 [Abstract] [Full Text] [Related]
9. Improvement by methylphenidate and atomoxetine of social interaction deficits and recognition memory impairment in a mouse model of valproic acid-induced autism. Hara Y, Ago Y, Taruta A, Katashiba K, Hasebe S, Takano E, Onaka Y, Hashimoto H, Matsuda T, Takuma K. Autism Res; 2016 Sep 01; 9(9):926-39. PubMed ID: 26714434 [Abstract] [Full Text] [Related]
10. Pentyl-4-yn-VPA, a histone deacetylase inhibitor, ameliorates deficits in social behavior and cognition in a rodent model of autism spectrum disorders. Foley AG, Cassidy AW, Regan CM. Eur J Pharmacol; 2014 Mar 15; 727():80-6. PubMed ID: 24486700 [Abstract] [Full Text] [Related]
16. Exposure to valproic acid during middle to late-stage corticogenesis induces learning and social behavioral abnormalities with attention deficit/hyperactivity in adult mice. Sakade Y, Yamanaka K, Soumiya H, Furukawa S, Fukumitsu H. Biomed Res; 2019 Mar 15; 40(5):179-188. PubMed ID: 31597903 [Abstract] [Full Text] [Related]
17. 5-aminolevulinic acid inhibits oxidative stress and ameliorates autistic-like behaviors in prenatal valproic acid-exposed rats. Matsuo K, Yabuki Y, Fukunaga K. Neuropharmacology; 2020 May 15; 168():107975. PubMed ID: 31991146 [Abstract] [Full Text] [Related]
18. Effect of prenatal valproic acid exposure on cortical morphology in female mice. Hara Y, Maeda Y, Kataoka S, Ago Y, Takuma K, Matsuda T. J Pharmacol Sci; 2012 May 15; 118(4):543-6. PubMed ID: 22447305 [Abstract] [Full Text] [Related]
19. Benefits of Fenofibrate in prenatal valproic acid-induced autism spectrum disorder related phenotype in rats. Mirza R, Sharma B. Brain Res Bull; 2019 Apr 15; 147():36-46. PubMed ID: 30769127 [Abstract] [Full Text] [Related]